Acute insulin resistance stimulates and insulin sensitization attenuates vascular smooth muscle cell migration and

Eugenio Cersosimo1, Xiaojing Xu1, Sikarin Upala2

  • 1Department of Medicine, Division of Diabetes and the Texas Diabetes Institute, University Health System and the University of Texas Health Science Center at San Antonio, San Antonio, Texas.

Physiological Reports
|August 21, 2014
PubMed
Abstract

Insights

High glucose and palmitate increase vascular smooth muscle cell migration and proliferation. The insulin sensitizer pioglitazone (PIO) significantly attenuates these effects, suggesting a role in atherosclerosis development.

Area of Science:

  • Cardiovascular Biology
  • Cellular Metabolism
  • Endocrinology

Background:

  • Insulin signaling pathways are differentially regulated by high glucose and palmitate in vascular smooth muscle cells (VSMCs).
  • Previous studies indicated molecular pathway alterations, but the biological impact on VSMC function remained unclear.

Purpose of the Study:

  • To investigate the effects of high glucose and palmitate, with or without the insulin sensitizer pioglitazone (PIO), on VSMC migration and proliferation.
  • To determine the functional consequences of altered insulin signaling in VSMCs under metabolic stress.

Main Methods:

  • Human coronary artery VSMCs were exposed to high glucose (25 mmol/L) and/or palmitate (200 μmol/L) with or without PIO (8 μmol/L).
  • VSMC migration was assessed using a membrane barrier assay (OD595 nm) and a 2D area expansion assay.
  • VSMC proliferation was evaluated by cell viability assays (absorbance).

Main Results:

  • High glucose significantly increased VSMC migration (~25%) and proliferation (~10%).
  • Pioglitazone significantly reduced migration (0.25 to 0.19) and proliferation (0.208 to 0.183).
  • High glucose combined with palmitate further modulated migration and proliferation, with PIO showing a marked reduction (50% decrease in radius change).

Conclusions:

  • High glucose and palmitate stimulate VSMC migration and proliferation in vitro.
  • Pioglitazone attenuates these pro-atherogenic VSMC functions.
  • These findings support the role of dysregulated insulin signaling in VSMCs in the pathogenesis of atherosclerosis, contributing to inflammation and plaque formation.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.2K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
12
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
5.9K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
54